Effects of weight loss in metabolically healthy obese subjects after laparoscopic adjustable gastric banding and hypocaloric diet

PLoS ONE

Volumn 6, Issue 3, 2011, Pages

  Sesti, Giorgio ^a   Folli, Franco ^b   Perego, Lucia ^c   Hribal, Marta Letizia ^a   Pontiroli, Antonio E ^c  

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^b University of Texas Health Science Center   (United States)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; TRIACYLGLYCEROL;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANTHROPOMETRY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BODY MASS; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIET RESTRICTION; FEMALE; GASTRIC BANDING; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; LOW CALORY DIET; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; METABOLIC PARAMETERS; MORBID OBESITY; ORAL GLUCOSE TOLERANCE TEST; RISK FACTOR; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; WEIGHT CHANGE; WEIGHT REDUCTION; FOLLOW UP; GASTROPLASTY; HEALTH; LAPAROSCOPY; METABOLISM; OBESITY; PATHOPHYSIOLOGY; PHYSIOLOGY;

ADULT; BODY MASS INDEX; DIET, REDUCING; FEMALE; FOLLOW-UP STUDIES; GASTROPLASTY; HEALTH; HUMANS; INSULIN RESISTANCE; LAPAROSCOPY; MALE; OBESITY; WEIGHT LOSS;

EID: 79952411379     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0017737     Document Type: Article

References (22)

1. Wildman RP, Muntner P, Reynolds K, McGinn AP, Rajpathak S, et al. (2008) The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004). Arch Intern Med 168: 1617-1624.
2. Meigs JB, Wilson PW, Fox CS, Vasan RS, Nathan DM, et al. (2006) Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease. J Clin Endocrinol Metab 91: 2906-2912.
3. Kuk JL, Ardern CI, (2009) Are metabolically normal but obese individuals at lower risk for all-cause mortality? Diabetes Care 32: 2297-2299.
4. Calori G, Lattuada G, Piemonti L, Garancini MP, Ragogna F, et al. (2011) Prevalence, metabolic features and prognosis of metabolically healthy obese Italian individuals: the Cremona Study. Diabetes Care 34: 210-215.
5. Brochu M, Tchernof A, Dionne IJ, Sites CK, Eltabbakh GH, et al. (2001) What are the physical characteristics associated with a normal metabolic profile despite a high level of obesity in postmenopausal women? J Clin Endocrinol Metab 86: 1020-1025.
6. Karelis AD, St-Pierre DH, Conus F, Rabasa-Lhoret R, Poehlman ET, (2004) Metabolic and body composition factors in subgroups of obesity: what do we know? J Clin Endocrinol Metab 89: 2569-2575.
7. Karelis AD, Faraj M, Bastard JP, St-Pierre DH, Brochu M, et al. (2005) The metabolically healthy but obese individual presents a favorable inflammation profile. J Clin Endocrinol Metab 90: 4145-4150.
8. Marini MA, Succurro E, Frontoni S, Hribal ML, Andreozzi F, et al. (2007) Metabolically healthy but obese women have an intermediate cardiovascular risk profile between healthy non-obese women and obese insulin resistant women. Diabetes Care 30: 2145-2147.
9. Stefan N, Kantartzis K, Machann J, Schick F, Thamer C, et al. (2008) Identification and characterization of metabolically benign obesity in humans. Arch Intern Med 168: 1609-1616.
10. Succurro E, Marini MA, Frontoni S, Hribal ML, Andreozzi F, et al. (2008) Insulin Secretion in Metabolically Obese, but Normal Weight, and in Metabolically Healthy but Obese Individuals. Obesity 16: 1881-1886.
11. Sesti G, Succurro E, Arturi F, Andreozzi F, Laino I, et al. (2010) IGF-1 levels link estimated glomerular filtration rate to insulin resistance in obesity: A study in obese, but metabolically healthy, subjects and obese, insulin-resistant subjects. Nutr Metab Cardiovasc Dis In press. DOI:10.1016/j.numecd.2010.02.008.
12. Shin MJ, Hyun YJ, Kim OY, Kim JY, Jang Y, et al. (2006) Weight loss effect on inflammation and LDL oxidation in metabolically healthy but obese (MHO) individuals: low inflammation and LDL oxidation in MHO women. Int J Obes (Lond) 30: 1529-1534.
13. Karelis AD, Messier V, Brochu M, Rabasa-Lhoret R, (2008) Metabolically healthy but obese women: effect of an energy-restricted diet. Diabetologia 51: 1752-1754.
14. Kantartzis K, Machann J, Schick F, Rittig K, Machicao F, et al. (2010) Effects of a lifestyle intervention in metabolically benign and malign obesity. Diabetologia In press. DOI: 10.1007/s00125-010-2006-3.
15. Janiszewski PM, Ross R, (2010) Effects of weight loss among metabolically healthy obese men and women. Diabetes Care 33: 1957-1959.
16. Pontiroli EA, Pizzocri P, Librenti MC, Vedani P, Marchi M, et al. (2002) Laparoscopic adjustable gastric banding for the treatment of morbid (grade 3) obesity and its metabolic complications: a three-year study. J Clin Endocrinol Metab 87: 3555-3561.
17. Pontiroli AE, Folli F, Paganelli M, Micheletto G, Pizzocri P, et al. (2005) Laparoscopic gastric banding prevents type 2 diabetes and arterial hypertension and induces their remission in morbid obesity: a 4-year case-controlled study. Diabetes Care 28: 2703-2709.
18. Sesti G, Perego L, Cardellini M, Andreozzi F, Ricasoli C, et al. (2005) Impact of common polymorphisms in candidate genes for insulin resistance and obesity on weight loss of morbidly obese subjects after laparoscopic adjustable gastric banding and hypocaloric diet. J Clin Endocrinol Metab 90: 5064-5069.
19. Matsuda M, DeFronzo RA, (1999) Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22: 1462-70.
20. Stumvoll M, Mitrakou A, Pimenta W, Jenssen T, Yki-Jarvinen H, et al. (2000) Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity. Diabetes Care 23: 295-301.
21. Succurro E, Marini MA, Arturi F, Grembiale A, Lugarà M, et al. (2009) Elevated one-hour post-load plasma glucose levels identifies subjects with normal glucose tolerance but early carotid atherosclerosis. Atherosclerosis 207: 245-249.
22. Succurro E, Arturi F, Lugarà M, Grembiale A, Fiorentino TV, et al. (2010) One-hour postload plasma glucose levels are associated with kidney dysfunction. Clin J Am Soc Nephrol 5: 1922-1927.